从IL-5转换为严重嗜酸性哮喘的IL-5-受体α抗体治疗。
J Asthma Allergy. 2020 Nov 11;13:605-614. doi: 10.2147/JAA.S270298. eCollection 2020.
J Asthma Allergy. 2020.
PMID:33204117
Free PMC article.